Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kintara Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 2.32M | Oct 18, 2024 | Direct | ||
Kintara Therapeutics, Inc. | Chief Executive Officer, Director | Options (Right to Buy) | 1.07M | Nov 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HURA | TuHURA Biosciences, Inc./NV | Nov 12, 2024 | 1 | $0 | 4 | Nov 14, 2024 | Chief Executive Officer, Director |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 4 | $0 | 4 | Oct 22, 2024 | Chief Executive Officer, Director |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Chief Executive Officer, Director |